Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy

SIMPLE SUMMARY: Anti-CD38 monoclonal antibody has improved the prognosis of relapsed/refractory multiple myeloma (RRMM) but some patients still experience early relapse with a poor outcome. We have here evaluated the predictive value of FDG PET/CT parameters prior to receiving anti-CD38-based therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouquet, Guillemette, Wartski, Myriam, Dechmi, Amina, Willems, Lise, Deau-Fischer, Bénédicte, Franchi, Patricia, Descroocq, Justine, Deschamps, Paul, Blanc-Autran, Estelle, Clerc, Jérôme, Bouscary, Didier, Barreau, Sylvain, Chapuis, Nicolas, Vignon, Marguerite, Cottereau, Anne-Ségolène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431719/
https://www.ncbi.nlm.nih.gov/pubmed/34503133
http://dx.doi.org/10.3390/cancers13174323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431719/
https://www.ncbi.nlm.nih.gov/pubmed/34503133
http://dx.doi.org/10.3390/cancers13174323

Ejemplares similares